Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor Grünwald

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Current Opinion in Urology|July 1, 2015
T-cell checkpoint inhibitors in metastatic renal cell carcinomaViktor Grünwald
Oncology Research and Treatment|June 5, 2016
Checkpoint Blockade - a New Treatment Paradigm in Renal Cell CarcinomaViktor Grünwald
The Lancet. Oncology|March 14, 2018
Aiming for complete responses in renal-cell carcinomaViktor Grünwald
Advances in Experimental Medicine and Biology|August 12, 2003
Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774)Viktor Grünwald, Manuel Hidalgo
Seminars in Oncology|June 13, 2003
Development of the epidermal growth factor receptor inhibitor OSI-774Viktor Grünwald, Manuel Hidalgo
Deutsches Arzteblatt International|July 2, 2014
Confusion of therapeutic approachesPhilipp Ivanyi, Viktor Grünwald
Deutsche Medizinische Wochenschrift (1946)|December 3, 2019
[Current Standard of Care in Squamous Cell Carcinoma of the Head and Neck (SCCHN) - Prevention, diagnostics, prognostication and therapy]Michael Pogorzelski, Viktor Grünwald
Oncology Research and Treatment|October 11, 2014
[Immuno-Oncology therapeutic principles in lung and renal cell carcinoma]Jürgen Wolf, Viktor Grünwald
World Journal of Urology|January 11, 2014
Systemic therapy of renal cell carcinomaViktor Grünwald, Alain Ravaud
Current Problems in Cancer|June 27, 2002
The epidermal growth factor receptor: a new target for anticancer therapyViktor Grünwald, Manuel Hidalgo
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Current Opinion in Urology|July 1, 2015
T-cell checkpoint inhibitors in metastatic renal cell carcinomaViktor Grünwald
Oncology Research and Treatment|June 5, 2016
Checkpoint Blockade - a New Treatment Paradigm in Renal Cell CarcinomaViktor Grünwald
The Lancet. Oncology|March 14, 2018
Aiming for complete responses in renal-cell carcinomaViktor Grünwald
Advances in Experimental Medicine and Biology|August 12, 2003
Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774)Viktor Grünwald, Manuel Hidalgo
Seminars in Oncology|June 13, 2003
Development of the epidermal growth factor receptor inhibitor OSI-774Viktor Grünwald, Manuel Hidalgo
Deutsches Arzteblatt International|July 2, 2014
Confusion of therapeutic approachesPhilipp Ivanyi, Viktor Grünwald
Deutsche Medizinische Wochenschrift (1946)|December 3, 2019
[Current Standard of Care in Squamous Cell Carcinoma of the Head and Neck (SCCHN) - Prevention, diagnostics, prognostication and therapy]Michael Pogorzelski, Viktor Grünwald
Oncology Research and Treatment|October 11, 2014
[Immuno-Oncology therapeutic principles in lung and renal cell carcinoma]Jürgen Wolf, Viktor Grünwald
World Journal of Urology|January 11, 2014
Systemic therapy of renal cell carcinomaViktor Grünwald, Alain Ravaud
Current Problems in Cancer|June 27, 2002
The epidermal growth factor receptor: a new target for anticancer therapyViktor Grünwald, Manuel Hidalgo
Pageof 26